Submit Post

User pushduck86

Member for: 4 months (since Aug 13)
Type: Registered user
First Name:
Last Name:
Location:
Website: https://www.selleckchem.com/products/fructose.html
About: Post-progression outcomes of NSCLC individuals with PD-L1 expression ≥ 50% getting first-line single-agent pembrolizumab in a huge multicentre real-world examine.
Company:
Skills:
Facebook Profile Link:
Twitter Profile Link:

Activity by pushduck86

Score: 10 points (ranked #91)
topics: 0
replies: 0
Comments: 0
Voted on: 0 topics, 0 replies
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

 

FlipThisWeb.com is an American website featuring resources for website owners.

Disclaimer : All featured content on this site is posted by community members and for information purpose only. Please consult with medical professionals for clarifications.

This site is run by Frankly Deals, LLC

Frankly Deals, LLC @ 2025. All rights reserved. 125 Galleria Drive, #1341, Cheektowaga, NY 14225.

...